Doubs and Côte d'Or viral hepatitis register FRESH-PEF220-en Anne MINELLO Doubs and Côte d'Or viral hepatitis register FRESH-PEF220-en 220 FRESH-PEF220 Anne MINELLO CENTRE HOSPITALIER UNIVERSITAIRE DE DIJON Epidemiology France Portal (PEF) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) SANTE PUBLIQUE FRANCE null Anne;MINELLO B virus C virus incidence Infectious disease medicine Hepatology Certain specified inflammatory liver diseases Hepatic cirrhosis Behavioral determinants Register objectives in terms of public health (monitoring, assessment) These concern two different methods: descriptive epidemiology and assessment of healthcare practices. The objective of the first method is health monitoring of B and C viral infections: - study of the detection rates of B and C viral serologies and of their trends over time, - study of the contamination method trends over time, - study of diagnostic techniques (systematic screening, diagnostic approach if biological anomalies or symptoms detected), - assessment of the impact of the change in the B viral vaccination campaign in 1998 on the incidence of acute hepatitis B. In the field of healthcare practice, our objectives are: - study of the arrangements for treating hepatitis B and C in the population in general, - assessment of the impact of consensus conferences and national recommendations of good clinical practice, - analysis of care sectors. Register's objectives in terms of research - Study of the natural history of hepatitis B and C in the cohort formed: causes of death, risk of complications. - Anthropological studies to understand what is hampering the treatment of hepatitis C sufferers and study of the determinants of the diagnosis and care proposal for immigrants suffering from hepatitis B null France Bourgogne Franche-Comté Individuals Patients population Male Female Infant, Newborn (birth to 28 days) Infant (28 days to 2 years) Child, Preschool (2 to 5 years) Child (6 to 12 years) Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Adults and Children carrying the HBs antigen (HBs Ag) and/or hepatitis C (HCV) antibodies Clinical data Biological data Socio-demographic data Health event/morbidity Health event/mortality Other [1000-10000[ individuals Other Observational Study Observational Study Morbidity registry 1994-2009: 3750 Unknown Restricted access access to the Register's data by request Access on specific project only